BioSpace News Archive

Meabco Inc. announced today that BP-C2, a drug being developed as a radioprotective and radiomitigative agent with applications in oncology and public health preparedness, was able to protect mice when administered 24 hours following lethal radiation exposure.

PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy solutions, announced today the expanded availability of the CapsoCam Plus® video capsule system,

bioAffinity Technologies, a privately held biotech company, and Smiths Medical, a leading global medical device manufacturer, today announced a partnership to improve patient care with at-home collection of sputum to be analyzed by CyPath® Lung, a non-invasive flow cytometry diagnostic test for lung cancer that is being developed as a Laboratory Developed Test (LDT) by Precision Pathology Services.

HealthScape Advisors, a Convey Health Solutions company, has been recognized and ranked as the No.1 Supplier in Modern Healthcare’s 2020 Best Places to Work in Healthcare, a national award that identifies and recognizes outstanding employers in the healthcare industry.

Biocom, the association representing the California life science industry, today announced a call for entries for the fifth annual Life Science Catalyst Awards from the Bay Area, San Diego and Los Angeles regions.

Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, with its subsidiary Kemin Biologics, has signed an exclusive agreement with Pacific GeneTech (PGT) to license PGT’s TMH001 Eimeria vaccine for poultry

STRAP Technologies announced today, on White Cane Safety Day in the United States, the creation of a hands-free device designed to be worn by the visually impaired to allow for more independence and mobility.

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the coronary Investigational Device Exemption (IDE) study, Disrupt CAD III, met the primary safety and effectiveness endpoints.

Varian (NYSE: VAR) today announced that its stockholders have voted to approve the previously announced pending combination with Siemens Healthineers AG (Frankfurt: SHL) at a special meeting

Parents and caregivers should not use any products containing benzocaine in children under two years of age because of the risk of MetHb.